跳至主要内容
临床试验/NCT03100695
NCT03100695Unknown不适用

A Prospective, Randomised, Single-centre Feasibility Study of Combined Autologous Platelet-rich Plasma and Concentrated Autologous Bone Marrow in Adult Patients With a Fresh Unilateral Tibial Diaphyseal Fracture Treated With Either Fine Wire Ring Fixator Device (Ilizarov) or Reamed Intramedullary Nailing

University of Leeds1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2018年10月4日最近更新:
适应症

试验速览

阶段
不适用
入组人数
45
试验地点
1
主要终点
Time to healing

研究概览

简要总结

A prospective, randomised study is to investigate the feasibility of conducting a superiority randomised controlled trial comparing the application of combined autologous PRP and concentrated autologous bone marrow (PRP-BMA) in addition to standard of care (either reamed intramedullary nailing or fine wire ring external fixator) for patients presenting with fresh tibial diaphyseal fractures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-65, skeletally mature adults.
  • Acute unilateral closed tibia diaphyseal fractures as the primary injury.
  • Definitive fracture fixation with reamed intramedullary nailing (statically locked) or fine wire ring external fixator to be performed within 14 days from the date of injury.
  • Willing and able (in the opinion of the study team) to provide informed consent and participate in all study activities.

排除标准

  • Open/compound tibial fracture.
  • Fracture Type 42-C2 according to Muller AO classification.
  • Multi-segmental nature of this fracture (more than one fracture site within tibia for intervention.)
  • Polytrauma (defined as injury severity score of 17 or more.)
  • Prior or concomitant illnesses that may affect healing.
  • Exposure to drugs that can affect the bone metabolic state within the past three months.
  • Receiving chemotherapy, radiation treatment or immunosuppression drugs.
  • Currently enrolled in any other study which may impact on the results of the present study.
  • If female: pregnancy, breast-feeding, not currently using and not willing to use an effective form of contraception for 12 months post-surgery.

结局指标

主要结局

Time to healing

时间窗: 2 weeks, 8 weeks, 12 weeks,16 weeks, 20 weeks, 26 weeks, 39 weeks

Healing will be assessed both clinically and radiologically (RUST score)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

PeterGiannoudis

Professor

University of Leeds

研究点 (1)

Loading locations...

相似试验